Literature DB >> 12757470

Effects of psychological group therapy in patients with multiple sclerosis.

N Tesar1, U Baumhackl, M Kopp, V Günther.   

Abstract

OBJECTIVES: The aim of this pilot study was to evaluate a psychological therapy program used in the treatment of multiple sclerosis (MS) and including cognitive/behavioral strategies, relaxation training and physical exercise.
MATERIAL AND METHODS: The participants were 29 patients with MS recruited from an outpatient unit; 14 patients were assigned to the 7-week psychological therapy group (one session per week), the remainder formed a control group. Before and immediately after the course of therapy and after a 2-month follow-up, the participants completed a series of questionnaires measuring factors such as depression, anxiety, coping and body image.
RESULTS: Compared with the control group the therapy group showed long-term improvements in depressive stress coping style and a short-term improvement in "vitality and body dynamics".
CONCLUSION: Further studies should investigate the differential effects of specific units of the therapy program and how the short-term improvements in "vitality and body dynamics" could be maintained for longer periods.

Entities:  

Mesh:

Year:  2003        PMID: 12757470     DOI: 10.1034/j.1600-0404.2003.00077.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  14 in total

1.  MS quality of life, depression, and fatigue improve after mindfulness training: a randomized trial.

Authors:  P Grossman; L Kappos; H Gensicke; M D'Souza; D C Mohr; I K Penner; C Steiner
Journal:  Neurology       Date:  2010-09-28       Impact factor: 9.910

2.  In-person and online social participation and emotional health in individuals with multiple sclerosis.

Authors:  Alica Sparling; Lauren A Stutts; Haley Sanner; Marleen M Eijkholt
Journal:  Qual Life Res       Date:  2017-07-12       Impact factor: 4.147

3.  Relaxation and health-related quality of life in multiple sclerosis: the example of autogenic training.

Authors:  Georgina Sutherland; Mark B Andersen; Tony Morris
Journal:  J Behav Med       Date:  2005-06

4.  Development and effectiveness of a psychoeducational wellness program for people with multiple sclerosis: description and outcomes.

Authors:  Kimberly Beckwith McGuire; Jelena Stojanovic-Radic; Lauren Strober; Nancy D Chiaravalloti; John DeLuca
Journal:  Int J MS Care       Date:  2015 Jan-Feb

Review 5.  Update on depression in neurologic illness: stroke, epilepsy, and multiple sclerosis.

Authors:  Richard M Sobel; Susan Lotkowski; Steven Mandel
Journal:  Curr Psychiatry Rep       Date:  2005-10       Impact factor: 5.285

6.  The effect of telephone-administered cognitive-behavioral therapy on quality of life among patients with multiple sclerosis.

Authors:  David Cosio; Ling Jin; Juned Siddique; David C Mohr
Journal:  Ann Behav Med       Date:  2011-04

7.  Neuropsychological deficits but not coping strategies are related to physical disability in multiple sclerosis.

Authors:  Claus G Haase; Marc Lienemann; Pedro M Faustmann
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-11-07       Impact factor: 5.270

8.  Multi-centre parallel arm randomised controlled trial to assess the effectiveness and cost-effectiveness of a group-based cognitive behavioural approach to managing fatigue in people with multiple sclerosis.

Authors:  Peter W Thomas; Sarah Thomas; Paula Kersten; Rosemary Jones; Alison Nock; Vicky Slingsby; Colin Green; Roger Baker; Kate Galvin; Charles Hillier
Journal:  BMC Neurol       Date:  2010-06-16       Impact factor: 2.474

Review 9.  Psychosocial interventions in people with multiple sclerosis: a review.

Authors:  K S Malcomson; L Dunwoody; A S Lowe-Strong
Journal:  J Neurol       Date:  2007-02-14       Impact factor: 4.849

10.  The impact of regular physical activity on fatigue, depression and quality of life in persons with multiple sclerosis.

Authors:  Nicole M Stroud; Clare L Minahan
Journal:  Health Qual Life Outcomes       Date:  2009-07-20       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.